Neurobionics : the biomedical engineering of neural prostheses / / edited by Robert K. Shepherd |
Pubbl/distr/stampa | Chichester, England : , : Wiley Blackwell, , 2016 |
Descrizione fisica | 1 online resource (357 p.) |
Disciplina | 610.28 |
Soggetto topico |
Myoelectric prosthesis
Neural networks (Computer science) Nervous system - Diseases - Treatment |
ISBN |
1-118-81603-X
1-118-81614-5 1-118-81602-1 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto | The historical foundation of bionics / Nick Donaldson and Giles S. Brindley -- Development of stable long-term electrode tissue interfaces for recording and stimulation / Jens Schouenborg -- Electrochemical principles of safe charge injection / Stuart F. Cogan, David J. Garrett and Rylie A. Green -- Principles of recording from an electrical stimulation of neural tissue / James B. Fallon and Paul M. Carter -- Wireless neurotechnology for neural prostheses / Arto Nurmikko, David Borton and Ming Yin -- Preclinical testing of neural prostheses / Douglas McCreery -- Auditory and visual neural prostheses / Robert K. Shepherd, Peter M. Seligman, Mohit N. Shivdasani -- Neurobionics : treatments for disorders of the central nervous system / Hugh McDermott -- Brain computer interfaces / David M. Brandman and Leigh R. Hochberg. |
Record Nr. | UNINA-9910823769803321 |
Chichester, England : , : Wiley Blackwell, , 2016 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Neurocritical care |
Pubbl/distr/stampa | Totowa, NJ, : Humana Press, 2004- |
Disciplina | 616.8 |
Soggetto topico |
Nervous system - Diseases - Treatment
Neurological intensive care Critical care medicine Nervous System Diseases - therapy Critical Care |
Soggetto genere / forma |
Periodicals.
Zeitschrift |
Soggetto non controllato | Neurology |
ISSN | 1556-0961 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910144217503321 |
Totowa, NJ, : Humana Press, 2004- | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Neurocritical care |
Pubbl/distr/stampa | Totowa, NJ, : Humana Press, 2004- |
Disciplina | 616.8 |
Soggetto topico |
Nervous system - Diseases - Treatment
Neurological intensive care Critical care medicine Nervous System Diseases - therapy Critical Care |
Soggetto genere / forma |
Periodicals.
Zeitschrift |
Soggetto non controllato | Neurology |
ISSN | 1556-0961 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Periodico |
Lingua di pubblicazione | eng |
Record Nr. | UNISA-996218441603316 |
Totowa, NJ, : Humana Press, 2004- | ||
![]() | ||
Lo trovi qui: Univ. di Salerno | ||
|
Neurocritical care board review [[electronic resource] /] / [edited by] Asma Zakaria |
Pubbl/distr/stampa | New York, NY, : Demos Medical Publishing, 2013 |
Descrizione fisica | 1 online resource : illustrations |
Disciplina | 616.02/8 |
Altri autori (Persone) | ZakariaAsma |
Soggetto topico |
Nervous system - Diseases - Treatment
Critical care medicine |
Soggetto genere / forma | Electronic books. |
ISBN | 1-61705-033-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Part I: Neurologic Disease States: Pathology, Pathophysiology, and Therapy; Section I: Cerebrovascular Diseases; Chapter 1: Infarction, Ischemia, and Hemorrhage; Chapter 2: Subarachnoid Hemorrhageand Vascular Malformations; Section II: lNeurotrauma; Chapter 3: lNeurotrauma; Section III: Disorders, Diseases, Seizures, and Epilepsy; Chapter 4: Seizures and Epilepsy; Chapter 5: Neuromuscular Medicine; Chapter 6: CNS Infections; Chapter 7: Toxic-Metabolic Disorders; Chapter 8: Inflammatory and Demyelinating Diseases
Chapter 9: Neuroendocrine DisordersChapter 10: lNeuro-Oncology; Chapter 11: Encephalopathies; Chapter 12: lClinical Syndromes; Chapter 13: Perioperative Neurosurgical Care; Chapter 14: Pharmacology and Practical Use of Medications in Neurocritical Care; Part II: General Critical Care: Pathology, Pathophysiology, and Therapy; Chapter 15: Cardiovascular Physiology; Chapter 16: Cardiovascular Diseases; Chapter 17: Pulmonary Physiology and Fundamentals of Mechanical Ventilation; Chapter 18: Respiratory Diseases; Chapter 19: Renal Diseases; Chapter 20: Electrolyte and Endocrine Disorders Chapter 21: Infectious DiseaseChapter 22: Acute Hematologic Disorders; Chapter 23: Acute Gastrointestinal and Genitourinary Disorders; Chapter 24: Diagnosis of Brain Death; Chapter 25: General Trauma and Burns; Chapter 26: Ethical and Legal Aspects of Critical Care Medicine; Chapter 27: Principles of Research in Critical Care; Chapter 28: Procedural Skills and Monitoring; Chapter 29: Clinical Cases; Index |
Record Nr. | UNINA-9910463116703321 |
New York, NY, : Demos Medical Publishing, 2013 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Neurocritical care board review [[electronic resource] /] / [edited by] Asma Zakaria |
Pubbl/distr/stampa | New York, NY, : Demos Medical Publishing, 2013 |
Descrizione fisica | 1 online resource : illustrations |
Disciplina | 616.02/8 |
Altri autori (Persone) | ZakariaAsma |
Soggetto topico |
Nervous system - Diseases - Treatment
Critical care medicine |
ISBN | 1-61705-033-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Part I: Neurologic Disease States: Pathology, Pathophysiology, and Therapy; Section I: Cerebrovascular Diseases; Chapter 1: Infarction, Ischemia, and Hemorrhage; Chapter 2: Subarachnoid Hemorrhageand Vascular Malformations; Section II: lNeurotrauma; Chapter 3: lNeurotrauma; Section III: Disorders, Diseases, Seizures, and Epilepsy; Chapter 4: Seizures and Epilepsy; Chapter 5: Neuromuscular Medicine; Chapter 6: CNS Infections; Chapter 7: Toxic-Metabolic Disorders; Chapter 8: Inflammatory and Demyelinating Diseases
Chapter 9: Neuroendocrine DisordersChapter 10: lNeuro-Oncology; Chapter 11: Encephalopathies; Chapter 12: lClinical Syndromes; Chapter 13: Perioperative Neurosurgical Care; Chapter 14: Pharmacology and Practical Use of Medications in Neurocritical Care; Part II: General Critical Care: Pathology, Pathophysiology, and Therapy; Chapter 15: Cardiovascular Physiology; Chapter 16: Cardiovascular Diseases; Chapter 17: Pulmonary Physiology and Fundamentals of Mechanical Ventilation; Chapter 18: Respiratory Diseases; Chapter 19: Renal Diseases; Chapter 20: Electrolyte and Endocrine Disorders Chapter 21: Infectious DiseaseChapter 22: Acute Hematologic Disorders; Chapter 23: Acute Gastrointestinal and Genitourinary Disorders; Chapter 24: Diagnosis of Brain Death; Chapter 25: General Trauma and Burns; Chapter 26: Ethical and Legal Aspects of Critical Care Medicine; Chapter 27: Principles of Research in Critical Care; Chapter 28: Procedural Skills and Monitoring; Chapter 29: Clinical Cases; Index |
Record Nr. | UNINA-9910787563903321 |
New York, NY, : Demos Medical Publishing, 2013 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Neurocritical care board review / / [edited by] Asma Zakaria |
Edizione | [1st ed.] |
Pubbl/distr/stampa | New York, NY, : Demos Medical Publishing, 2013 |
Descrizione fisica | 1 online resource : illustrations |
Disciplina | 616.02/8 |
Altri autori (Persone) | ZakariaAsma |
Soggetto topico |
Nervous system - Diseases - Treatment
Critical care medicine |
ISBN | 1-61705-033-4 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Cover; Title; Copyright; Contents; Contributors; Preface; Part I: Neurologic Disease States: Pathology, Pathophysiology, and Therapy; Section I: Cerebrovascular Diseases; Chapter 1: Infarction, Ischemia, and Hemorrhage; Chapter 2: Subarachnoid Hemorrhageand Vascular Malformations; Section II: lNeurotrauma; Chapter 3: lNeurotrauma; Section III: Disorders, Diseases, Seizures, and Epilepsy; Chapter 4: Seizures and Epilepsy; Chapter 5: Neuromuscular Medicine; Chapter 6: CNS Infections; Chapter 7: Toxic-Metabolic Disorders; Chapter 8: Inflammatory and Demyelinating Diseases
Chapter 9: Neuroendocrine DisordersChapter 10: lNeuro-Oncology; Chapter 11: Encephalopathies; Chapter 12: lClinical Syndromes; Chapter 13: Perioperative Neurosurgical Care; Chapter 14: Pharmacology and Practical Use of Medications in Neurocritical Care; Part II: General Critical Care: Pathology, Pathophysiology, and Therapy; Chapter 15: Cardiovascular Physiology; Chapter 16: Cardiovascular Diseases; Chapter 17: Pulmonary Physiology and Fundamentals of Mechanical Ventilation; Chapter 18: Respiratory Diseases; Chapter 19: Renal Diseases; Chapter 20: Electrolyte and Endocrine Disorders Chapter 21: Infectious DiseaseChapter 22: Acute Hematologic Disorders; Chapter 23: Acute Gastrointestinal and Genitourinary Disorders; Chapter 24: Diagnosis of Brain Death; Chapter 25: General Trauma and Burns; Chapter 26: Ethical and Legal Aspects of Critical Care Medicine; Chapter 27: Principles of Research in Critical Care; Chapter 28: Procedural Skills and Monitoring; Chapter 29: Clinical Cases; Index |
Record Nr. | UNINA-9910821594203321 |
New York, NY, : Demos Medical Publishing, 2013 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Neurology evidence : the practice-changing studies / / Erik L. Antonsen, Arjun K. Venkatesh |
Autore | Antonsen Erik L. |
Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer, , [2017] |
Descrizione fisica | 1 online resource (337 pages) |
Disciplina | 616.8046 |
Soggetto topico | Nervous system - Diseases - Treatment |
ISBN | 1-4963-4895-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Title Page -- Copyright -- DEDICATION -- CONTRIBUTORS -- FOREWORD -- PREFACE -- ACKNOWLEDGMENTS -- CONTENTS -- SECTION 1: ISCHEMIC STROKE -- 1. Intravenous tPA for Acute Ischemic Stroke -- 2. Aspirin for Secondary Stroke Prevention -- 3. Mechanical Thrombectomy for Large Vessel Occlusion -- 4. Harm from Stenting of Symptomatic Intracranial Arterial Stenoses -- 5. Warfarin for Atrial Fibrillation -- 6. Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation -- 7. Intense Low-Density Lipoprotein Cholesterol Reduction for Stroke Prevention -- 8. Marginal Benefit from Device Closure of Patent Foramen Ovale -- 9. Early Decompressive Surgery in Malignant Infarction of the Middle Cerebral Artery -- 10. Carotid Endarterectomy for Stroke Prevention in Internal Carotid Artery Stenosis -- 11. Carotid Artery Stenting vs. Carotid Endarterectomy For Symptomatic and Asymptomatic Carotid Artery Stenosis -- 12. Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm -- 13. Short-Term Dual Antiplatelet Therapy for Stroke Prevention after TIA or Minor Stroke -- 14. Aspirin Over Warfarin for Symptomatic Intracranial Stenosis -- 15. Lack of Benefit from Long-Term Dual Antiplatelet Therapy for Secondary Stroke Prevention -- 16. Fluoxetine for Motor Recovery after Acute Ischemic Stroke -- 17. Carotid Endarterectomy for Asymptomatic Carotid Artery Stenosis -- 18. Extended Monitoring for Paroxysmal Atrial Fibrillation -- 19. The National Institutes of Health Stroke Scale -- SECTION 2: CEREBRAL HEMORRHAGE -- 20. Blood Pressure Regulation in Parenchymal Intracerebral Hemorrhage -- 21. Early Surgery for Spontaneous Intracerebral Hemorrhage and Hydrocephalus -- 22. Avoidance of Long-Term Anticoagulation for Atrial Fibrillation after Intracerebral Hemorrhage.
23. Nimodipine for Prevention of Delayed Neurologic Injury after Subarachnoid Hemorrhage -- 24. Inferiority of Surgical Resection to Medical Management of Unruptured AVM -- 25. Prognostication for Intracerebral Hemorrhage -- 26. Acute Endovascular Treatment for Ruptured Subarachnoid Hemorrhage -- 27. Neurosurgical Clipping vs. Endovascular Coiling of Ruptured Intracranial Aneurysms -- 28. Withdrawal of Support in Intracerebral Hemorrhage because of Predicted Poor Prognosis May Lead to Self-Fulfilling Prophecy -- 29. rtPA for Intraventricular Hemorrhage -- 30. Grading of Ruptured Subarachnoid Hemorrhages -- SECTION 3: TRAUMATIC BRAIN INJURY -- 31. Glasgow Coma Scale -- 32. Albumin vs. Saline for Resuscitation after Traumatic Brain Injury -- 33. Decompressive Craniectomy in Traumatic Brain Injury -- 34. Antiepileptic Drugs after Traumatic Brain Injury -- 35. Intracranial Pressure Monitoring in Traumatic Brain Injury -- 36. Amantadine for Recovery of Consciousness after Traumatic Brain Injury -- 37. Functional Imaging in Vegetative States -- 38. Corticosteroids for Traumatic Brain Injury -- 39. Corticosteroids in Acute Spinal Cord Injury -- SECTION 4: NEUROLOGIC INTENSIVE CARE -- 40. Midline Shift and Level of Consciousness -- 41. Use of Hyperosmolar Therapy for Cerebral Edema -- 42. Hyperventilation for Acute Intracranial Pressure Elevation -- 43. Temperature Management for Cardiac Arrest in Adults -- 44. Early Mobilization in the Intensive Care Unit -- SECTION 5: NEUROINFECTIOUS DISEASES -- 45. Glucocorticoids for Bacterial Meningitis in Adults -- 46. Acyclovir for Herpes Simplex Encephalitis -- 47. Polymerase Chain Reaction Testing for Herpes Simplex Encephalitis -- 48. Antifungal Therapy for Cryptococcal Meningitis -- 49. Guidelines for Treatment of Lyme Disease in the Nervous System -- SECTION 6: NEURO-ONCOLOGY -- 50. Temozolomide for Glioblastoma. 51. Surgery for Brain Metastases -- 52. Chemotherapy for Low-Grade Glioma -- 53. NovoTTF for Newly Diagnosed Glioblastoma -- 54. Bevacizumab for Recurrent Glioblastoma -- 55. Methotrexate for Primary CNS Lymphoma -- SECTION 7: NEUROMUSCULAR -- 56. Acute Treatment for Guillain-Barre Syndrome -- 57. Alternate Day Prednisone in Myasthenia Gravis -- 58. IVIg vs. Prednisone for Chronic Inflammatory Demyelinating Polyneuropathy -- 59. Glucocorticoid Steroids for Duchenne Muscular Dystrophy -- 60. Riluzole in Amyotrophic Lateral Sclerosis -- 61. Thymectomy in Myasthenia Gravis -- SECTION 8: MOVEMENT DISORDERS -- 62. L-Dopa for Parkinson's Disease -- 63. Deep Brain Stimulation for Parkinson's Disease -- 64. Deep Brain Stimulation for Dystonia -- 65. L-Dopa vs. MAO-B Inhibitors in Parkinson's Disease -- 66. Propranolol Treatment for Essential Tremor -- 67. Rasagiline in Parkinson's Disease -- 68. Botulinum a Toxin for Dystonia -- SECTION 9: MULTIPLE SCLEROSIS -- 69. Progressive Multifocal Leukoencephalopathy after Treatment with Natalizumab -- 70. Glucocorticoids for Optic Neuritis: The Optic Neuritis Treatment Trial -- 71. Neuromyelitis Optica Antibody in the Diagnosis of Neuromyelitis Optica -- 72. Correlation Between MRI Findings and Disability in Multiple Sclerosis -- 73. The Association of Vitamin D Levels and Multiple Sclerosis -- 74. Rate of Pregnancy-Related Relapse in Multiple Sclerosis -- SECTION 10: AUTOIMMUNE NEUROLOGY -- 75. EULAR Recommendations for Treatment of Primary CNS Vasculitis -- 76. NMDA-ab Receptor Encephalitis with Ovarian Teratoma -- 77. Identification of Sjogren's Syndrome Associated Ganglionopathy -- 78. IVIG for Stiff Person Syndrome -- SECTION 11: EPILEPSY -- 79. Lorazepam for Treatment of Status Epilepticus -- 80. Magnesium for the Prevention of Eclampsia -- 81. Antiepileptic Drug Treatment after a First Unprovoked Seizure. 82. Intravenous vs. Intramuscular Benzodiazepines for Status Epilepticus -- 83. Continuous EEG Monitoring for Evaluation of Nonconvulsive Status Epilepticus -- SECTION 12: HEADACHE AND PAIN -- 84. Sumatriptan for Migraine -- 85. Topiramate for Migraine Prevention -- 86. Duloxetine for Chemo-Induced Painful Neuropathy -- 87. Pregabalin for Neuropathic Pain -- 88. Amitriptyline Prophylaxis for Headache -- 89. Divalproex for Migraine Prophylaxis -- SECTION 13: COGNITIVE NEUROLOGY -- 90. Donepezil for Alzheimer's Disease -- 91. Memantine in Addition to Donepezil for Alzheimer's Disease -- 92. Rivastigmine for Dementia with Lewy Bodies -- 93. Melatonin for REM Sleep Behavior Disorder -- 94. Agitation in Dementia -- SECTION 14: PEDIATRIC NEUROLOGY -- 95. Treatment of Infantile Spasms -- 96. Pharmaco vs. Behavioral Therapy for ADHD -- 97. Ketogenic Diet for the Treatment of Childhood Epilepsy -- 98. Hypothermia for Neonates with Hypoxic-Ischemic Encephalopathy -- 99. Febrile Seizures -- 100. When to Stop Antiepileptic Drugs in Children with Epilepsy -- INDEX. |
Record Nr. | UNINA-9910796535203321 |
Antonsen Erik L.
![]() |
||
Philadelphia : , : Wolters Kluwer, , [2017] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Neurology evidence : the practice-changing studies / / Erik L. Antonsen, Arjun K. Venkatesh |
Autore | Antonsen Erik L. |
Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer, , [2017] |
Descrizione fisica | 1 online resource (337 pages) |
Disciplina | 616.8046 |
Soggetto topico | Nervous system - Diseases - Treatment |
ISBN | 1-4963-4895-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Title Page -- Copyright -- DEDICATION -- CONTRIBUTORS -- FOREWORD -- PREFACE -- ACKNOWLEDGMENTS -- CONTENTS -- SECTION 1: ISCHEMIC STROKE -- 1. Intravenous tPA for Acute Ischemic Stroke -- 2. Aspirin for Secondary Stroke Prevention -- 3. Mechanical Thrombectomy for Large Vessel Occlusion -- 4. Harm from Stenting of Symptomatic Intracranial Arterial Stenoses -- 5. Warfarin for Atrial Fibrillation -- 6. Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation -- 7. Intense Low-Density Lipoprotein Cholesterol Reduction for Stroke Prevention -- 8. Marginal Benefit from Device Closure of Patent Foramen Ovale -- 9. Early Decompressive Surgery in Malignant Infarction of the Middle Cerebral Artery -- 10. Carotid Endarterectomy for Stroke Prevention in Internal Carotid Artery Stenosis -- 11. Carotid Artery Stenting vs. Carotid Endarterectomy For Symptomatic and Asymptomatic Carotid Artery Stenosis -- 12. Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm -- 13. Short-Term Dual Antiplatelet Therapy for Stroke Prevention after TIA or Minor Stroke -- 14. Aspirin Over Warfarin for Symptomatic Intracranial Stenosis -- 15. Lack of Benefit from Long-Term Dual Antiplatelet Therapy for Secondary Stroke Prevention -- 16. Fluoxetine for Motor Recovery after Acute Ischemic Stroke -- 17. Carotid Endarterectomy for Asymptomatic Carotid Artery Stenosis -- 18. Extended Monitoring for Paroxysmal Atrial Fibrillation -- 19. The National Institutes of Health Stroke Scale -- SECTION 2: CEREBRAL HEMORRHAGE -- 20. Blood Pressure Regulation in Parenchymal Intracerebral Hemorrhage -- 21. Early Surgery for Spontaneous Intracerebral Hemorrhage and Hydrocephalus -- 22. Avoidance of Long-Term Anticoagulation for Atrial Fibrillation after Intracerebral Hemorrhage.
23. Nimodipine for Prevention of Delayed Neurologic Injury after Subarachnoid Hemorrhage -- 24. Inferiority of Surgical Resection to Medical Management of Unruptured AVM -- 25. Prognostication for Intracerebral Hemorrhage -- 26. Acute Endovascular Treatment for Ruptured Subarachnoid Hemorrhage -- 27. Neurosurgical Clipping vs. Endovascular Coiling of Ruptured Intracranial Aneurysms -- 28. Withdrawal of Support in Intracerebral Hemorrhage because of Predicted Poor Prognosis May Lead to Self-Fulfilling Prophecy -- 29. rtPA for Intraventricular Hemorrhage -- 30. Grading of Ruptured Subarachnoid Hemorrhages -- SECTION 3: TRAUMATIC BRAIN INJURY -- 31. Glasgow Coma Scale -- 32. Albumin vs. Saline for Resuscitation after Traumatic Brain Injury -- 33. Decompressive Craniectomy in Traumatic Brain Injury -- 34. Antiepileptic Drugs after Traumatic Brain Injury -- 35. Intracranial Pressure Monitoring in Traumatic Brain Injury -- 36. Amantadine for Recovery of Consciousness after Traumatic Brain Injury -- 37. Functional Imaging in Vegetative States -- 38. Corticosteroids for Traumatic Brain Injury -- 39. Corticosteroids in Acute Spinal Cord Injury -- SECTION 4: NEUROLOGIC INTENSIVE CARE -- 40. Midline Shift and Level of Consciousness -- 41. Use of Hyperosmolar Therapy for Cerebral Edema -- 42. Hyperventilation for Acute Intracranial Pressure Elevation -- 43. Temperature Management for Cardiac Arrest in Adults -- 44. Early Mobilization in the Intensive Care Unit -- SECTION 5: NEUROINFECTIOUS DISEASES -- 45. Glucocorticoids for Bacterial Meningitis in Adults -- 46. Acyclovir for Herpes Simplex Encephalitis -- 47. Polymerase Chain Reaction Testing for Herpes Simplex Encephalitis -- 48. Antifungal Therapy for Cryptococcal Meningitis -- 49. Guidelines for Treatment of Lyme Disease in the Nervous System -- SECTION 6: NEURO-ONCOLOGY -- 50. Temozolomide for Glioblastoma. 51. Surgery for Brain Metastases -- 52. Chemotherapy for Low-Grade Glioma -- 53. NovoTTF for Newly Diagnosed Glioblastoma -- 54. Bevacizumab for Recurrent Glioblastoma -- 55. Methotrexate for Primary CNS Lymphoma -- SECTION 7: NEUROMUSCULAR -- 56. Acute Treatment for Guillain-Barre Syndrome -- 57. Alternate Day Prednisone in Myasthenia Gravis -- 58. IVIg vs. Prednisone for Chronic Inflammatory Demyelinating Polyneuropathy -- 59. Glucocorticoid Steroids for Duchenne Muscular Dystrophy -- 60. Riluzole in Amyotrophic Lateral Sclerosis -- 61. Thymectomy in Myasthenia Gravis -- SECTION 8: MOVEMENT DISORDERS -- 62. L-Dopa for Parkinson's Disease -- 63. Deep Brain Stimulation for Parkinson's Disease -- 64. Deep Brain Stimulation for Dystonia -- 65. L-Dopa vs. MAO-B Inhibitors in Parkinson's Disease -- 66. Propranolol Treatment for Essential Tremor -- 67. Rasagiline in Parkinson's Disease -- 68. Botulinum a Toxin for Dystonia -- SECTION 9: MULTIPLE SCLEROSIS -- 69. Progressive Multifocal Leukoencephalopathy after Treatment with Natalizumab -- 70. Glucocorticoids for Optic Neuritis: The Optic Neuritis Treatment Trial -- 71. Neuromyelitis Optica Antibody in the Diagnosis of Neuromyelitis Optica -- 72. Correlation Between MRI Findings and Disability in Multiple Sclerosis -- 73. The Association of Vitamin D Levels and Multiple Sclerosis -- 74. Rate of Pregnancy-Related Relapse in Multiple Sclerosis -- SECTION 10: AUTOIMMUNE NEUROLOGY -- 75. EULAR Recommendations for Treatment of Primary CNS Vasculitis -- 76. NMDA-ab Receptor Encephalitis with Ovarian Teratoma -- 77. Identification of Sjogren's Syndrome Associated Ganglionopathy -- 78. IVIG for Stiff Person Syndrome -- SECTION 11: EPILEPSY -- 79. Lorazepam for Treatment of Status Epilepticus -- 80. Magnesium for the Prevention of Eclampsia -- 81. Antiepileptic Drug Treatment after a First Unprovoked Seizure. 82. Intravenous vs. Intramuscular Benzodiazepines for Status Epilepticus -- 83. Continuous EEG Monitoring for Evaluation of Nonconvulsive Status Epilepticus -- SECTION 12: HEADACHE AND PAIN -- 84. Sumatriptan for Migraine -- 85. Topiramate for Migraine Prevention -- 86. Duloxetine for Chemo-Induced Painful Neuropathy -- 87. Pregabalin for Neuropathic Pain -- 88. Amitriptyline Prophylaxis for Headache -- 89. Divalproex for Migraine Prophylaxis -- SECTION 13: COGNITIVE NEUROLOGY -- 90. Donepezil for Alzheimer's Disease -- 91. Memantine in Addition to Donepezil for Alzheimer's Disease -- 92. Rivastigmine for Dementia with Lewy Bodies -- 93. Melatonin for REM Sleep Behavior Disorder -- 94. Agitation in Dementia -- SECTION 14: PEDIATRIC NEUROLOGY -- 95. Treatment of Infantile Spasms -- 96. Pharmaco vs. Behavioral Therapy for ADHD -- 97. Ketogenic Diet for the Treatment of Childhood Epilepsy -- 98. Hypothermia for Neonates with Hypoxic-Ischemic Encephalopathy -- 99. Febrile Seizures -- 100. When to Stop Antiepileptic Drugs in Children with Epilepsy -- INDEX. |
Record Nr. | UNINA-9910812078103321 |
Antonsen Erik L.
![]() |
||
Philadelphia : , : Wolters Kluwer, , [2017] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Neurology evidence : the practice-changing studies / / Kate T. Brizzi [and three others] |
Autore | Brizzi Kate T. |
Pubbl/distr/stampa | Philadelphia : , : Wolters Kluwer, , [2017] |
Descrizione fisica | 1 online resource (337 pages) |
Disciplina | 616.8046 |
Soggetto topico | Nervous system - Diseases - Treatment |
Soggetto genere / forma | Electronic books. |
ISBN | 1-4963-4895-8 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Nota di contenuto |
Intro -- Title Page -- Copyright -- DEDICATION -- CONTRIBUTORS -- FOREWORD -- PREFACE -- ACKNOWLEDGMENTS -- CONTENTS -- SECTION 1: ISCHEMIC STROKE -- 1. Intravenous tPA for Acute Ischemic Stroke -- 2. Aspirin for Secondary Stroke Prevention -- 3. Mechanical Thrombectomy for Large Vessel Occlusion -- 4. Harm from Stenting of Symptomatic Intracranial Arterial Stenoses -- 5. Warfarin for Atrial Fibrillation -- 6. Novel Oral Anticoagulants for Stroke Prevention in Nonvalvular Atrial Fibrillation -- 7. Intense Low-Density Lipoprotein Cholesterol Reduction for Stroke Prevention -- 8. Marginal Benefit from Device Closure of Patent Foramen Ovale -- 9. Early Decompressive Surgery in Malignant Infarction of the Middle Cerebral Artery -- 10. Carotid Endarterectomy for Stroke Prevention in Internal Carotid Artery Stenosis -- 11. Carotid Artery Stenting vs. Carotid Endarterectomy For Symptomatic and Asymptomatic Carotid Artery Stenosis -- 12. Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm -- 13. Short-Term Dual Antiplatelet Therapy for Stroke Prevention after TIA or Minor Stroke -- 14. Aspirin Over Warfarin for Symptomatic Intracranial Stenosis -- 15. Lack of Benefit from Long-Term Dual Antiplatelet Therapy for Secondary Stroke Prevention -- 16. Fluoxetine for Motor Recovery after Acute Ischemic Stroke -- 17. Carotid Endarterectomy for Asymptomatic Carotid Artery Stenosis -- 18. Extended Monitoring for Paroxysmal Atrial Fibrillation -- 19. The National Institutes of Health Stroke Scale -- SECTION 2: CEREBRAL HEMORRHAGE -- 20. Blood Pressure Regulation in Parenchymal Intracerebral Hemorrhage -- 21. Early Surgery for Spontaneous Intracerebral Hemorrhage and Hydrocephalus -- 22. Avoidance of Long-Term Anticoagulation for Atrial Fibrillation after Intracerebral Hemorrhage.
23. Nimodipine for Prevention of Delayed Neurologic Injury after Subarachnoid Hemorrhage -- 24. Inferiority of Surgical Resection to Medical Management of Unruptured AVM -- 25. Prognostication for Intracerebral Hemorrhage -- 26. Acute Endovascular Treatment for Ruptured Subarachnoid Hemorrhage -- 27. Neurosurgical Clipping vs. Endovascular Coiling of Ruptured Intracranial Aneurysms -- 28. Withdrawal of Support in Intracerebral Hemorrhage because of Predicted Poor Prognosis May Lead to Self-Fulfilling Prophecy -- 29. rtPA for Intraventricular Hemorrhage -- 30. Grading of Ruptured Subarachnoid Hemorrhages -- SECTION 3: TRAUMATIC BRAIN INJURY -- 31. Glasgow Coma Scale -- 32. Albumin vs. Saline for Resuscitation after Traumatic Brain Injury -- 33. Decompressive Craniectomy in Traumatic Brain Injury -- 34. Antiepileptic Drugs after Traumatic Brain Injury -- 35. Intracranial Pressure Monitoring in Traumatic Brain Injury -- 36. Amantadine for Recovery of Consciousness after Traumatic Brain Injury -- 37. Functional Imaging in Vegetative States -- 38. Corticosteroids for Traumatic Brain Injury -- 39. Corticosteroids in Acute Spinal Cord Injury -- SECTION 4: NEUROLOGIC INTENSIVE CARE -- 40. Midline Shift and Level of Consciousness -- 41. Use of Hyperosmolar Therapy for Cerebral Edema -- 42. Hyperventilation for Acute Intracranial Pressure Elevation -- 43. Temperature Management for Cardiac Arrest in Adults -- 44. Early Mobilization in the Intensive Care Unit -- SECTION 5: NEUROINFECTIOUS DISEASES -- 45. Glucocorticoids for Bacterial Meningitis in Adults -- 46. Acyclovir for Herpes Simplex Encephalitis -- 47. Polymerase Chain Reaction Testing for Herpes Simplex Encephalitis -- 48. Antifungal Therapy for Cryptococcal Meningitis -- 49. Guidelines for Treatment of Lyme Disease in the Nervous System -- SECTION 6: NEURO-ONCOLOGY -- 50. Temozolomide for Glioblastoma. 51. Surgery for Brain Metastases -- 52. Chemotherapy for Low-Grade Glioma -- 53. NovoTTF for Newly Diagnosed Glioblastoma -- 54. Bevacizumab for Recurrent Glioblastoma -- 55. Methotrexate for Primary CNS Lymphoma -- SECTION 7: NEUROMUSCULAR -- 56. Acute Treatment for Guillain-Barre Syndrome -- 57. Alternate Day Prednisone in Myasthenia Gravis -- 58. IVIg vs. Prednisone for Chronic Inflammatory Demyelinating Polyneuropathy -- 59. Glucocorticoid Steroids for Duchenne Muscular Dystrophy -- 60. Riluzole in Amyotrophic Lateral Sclerosis -- 61. Thymectomy in Myasthenia Gravis -- SECTION 8: MOVEMENT DISORDERS -- 62. L-Dopa for Parkinson's Disease -- 63. Deep Brain Stimulation for Parkinson's Disease -- 64. Deep Brain Stimulation for Dystonia -- 65. L-Dopa vs. MAO-B Inhibitors in Parkinson's Disease -- 66. Propranolol Treatment for Essential Tremor -- 67. Rasagiline in Parkinson's Disease -- 68. Botulinum a Toxin for Dystonia -- SECTION 9: MULTIPLE SCLEROSIS -- 69. Progressive Multifocal Leukoencephalopathy after Treatment with Natalizumab -- 70. Glucocorticoids for Optic Neuritis: The Optic Neuritis Treatment Trial -- 71. Neuromyelitis Optica Antibody in the Diagnosis of Neuromyelitis Optica -- 72. Correlation Between MRI Findings and Disability in Multiple Sclerosis -- 73. The Association of Vitamin D Levels and Multiple Sclerosis -- 74. Rate of Pregnancy-Related Relapse in Multiple Sclerosis -- SECTION 10: AUTOIMMUNE NEUROLOGY -- 75. EULAR Recommendations for Treatment of Primary CNS Vasculitis -- 76. NMDA-ab Receptor Encephalitis with Ovarian Teratoma -- 77. Identification of Sjogren's Syndrome Associated Ganglionopathy -- 78. IVIG for Stiff Person Syndrome -- SECTION 11: EPILEPSY -- 79. Lorazepam for Treatment of Status Epilepticus -- 80. Magnesium for the Prevention of Eclampsia -- 81. Antiepileptic Drug Treatment after a First Unprovoked Seizure. 82. Intravenous vs. Intramuscular Benzodiazepines for Status Epilepticus -- 83. Continuous EEG Monitoring for Evaluation of Nonconvulsive Status Epilepticus -- SECTION 12: HEADACHE AND PAIN -- 84. Sumatriptan for Migraine -- 85. Topiramate for Migraine Prevention -- 86. Duloxetine for Chemo-Induced Painful Neuropathy -- 87. Pregabalin for Neuropathic Pain -- 88. Amitriptyline Prophylaxis for Headache -- 89. Divalproex for Migraine Prophylaxis -- SECTION 13: COGNITIVE NEUROLOGY -- 90. Donepezil for Alzheimer's Disease -- 91. Memantine in Addition to Donepezil for Alzheimer's Disease -- 92. Rivastigmine for Dementia with Lewy Bodies -- 93. Melatonin for REM Sleep Behavior Disorder -- 94. Agitation in Dementia -- SECTION 14: PEDIATRIC NEUROLOGY -- 95. Treatment of Infantile Spasms -- 96. Pharmaco vs. Behavioral Therapy for ADHD -- 97. Ketogenic Diet for the Treatment of Childhood Epilepsy -- 98. Hypothermia for Neonates with Hypoxic-Ischemic Encephalopathy -- 99. Febrile Seizures -- 100. When to Stop Antiepileptic Drugs in Children with Epilepsy -- INDEX. |
Record Nr. | UNINA-9910467437803321 |
Brizzi Kate T.
![]() |
||
Philadelphia : , : Wolters Kluwer, , [2017] | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|
Neurology image-based clinical review / / Jonathan Howard, Anuradha Singh |
Autore | Howard Jonathan <1975-> |
Pubbl/distr/stampa | New York, [New York] : , : Demos Medical Publishing, , 2017 |
Descrizione fisica | 1 online resource (578 pages) : illustrations (some color) |
Disciplina | 616.80475 |
Soggetto topico |
Nervous system - Diseases - Diagnosis
Nervous system - Diseases - Treatment Diagnostic Techniques, Neurological Nervous System Diseases - therapy Neuroimaging Neurologic Examination Diagnosis, Differential |
Soggetto genere / forma |
Case Reports.
Electronic books. |
ISBN | 1-61705-280-9 |
Formato | Materiale a stampa ![]() |
Livello bibliografico | Monografia |
Lingua di pubblicazione | eng |
Record Nr. | UNINA-9910466023403321 |
Howard Jonathan <1975->
![]() |
||
New York, [New York] : , : Demos Medical Publishing, , 2017 | ||
![]() | ||
Lo trovi qui: Univ. Federico II | ||
|